Found: 22
Select item for more details and to access through your institution.
Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 559, doi. 10.1007/s00280-007-0635-0
- By:
- Publication type:
- Article
c-Jun-NH<sub>2</sub>-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 569, doi. 10.1007/s00280-007-0638-x
- By:
- Publication type:
- Article
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 577, doi. 10.1007/s00280-007-0640-3
- By:
- Publication type:
- Article
Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 585, doi. 10.1007/s00280-007-0642-1
- By:
- Publication type:
- Article
Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP)
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 595, doi. 10.1007/s00280-007-0643-0
- By:
- Publication type:
- Article
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 605, doi. 10.1007/s00280-007-0644-z
- By:
- Publication type:
- Article
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 621, doi. 10.1007/s00280-007-0645-y
- By:
- Publication type:
- Article
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 631, doi. 10.1007/s00280-007-0646-x
- By:
- Publication type:
- Article
Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 647, doi. 10.1007/s00280-007-0647-9
- By:
- Publication type:
- Article
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 655, doi. 10.1007/s00280-007-0649-7
- By:
- Publication type:
- Article
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 667, doi. 10.1007/s00280-007-0652-z
- By:
- Publication type:
- Article
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 673, doi. 10.1007/s00280-007-0653-y
- By:
- Publication type:
- Article
Pharmacokinetics of heated intraperitoneal oxaliplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 679, doi. 10.1007/s00280-007-0654-x
- By:
- Publication type:
- Article
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 685, doi. 10.1007/s00280-007-0655-9
- By:
- Publication type:
- Article
BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 689, doi. 10.1007/s00280-007-0657-7
- By:
- Publication type:
- Article
Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 699, doi. 10.1007/s00280-008-0725-7
- By:
- Publication type:
- Article
Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 707, doi. 10.1007/s00280-008-0755-1
- By:
- Publication type:
- Article
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 717, doi. 10.1007/s00280-007-0650-1
- By:
- Publication type:
- Article
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 727, doi. 10.1007/s00280-007-0656-8
- By:
- Publication type:
- Article
Imatinib inhibition of fludarabine uptake in T-lymphocytes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 735, doi. 10.1007/s00280-007-0629-y
- By:
- Publication type:
- Article
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 741, doi. 10.1007/s00280-007-0651-0
- By:
- Publication type:
- Article